Literature DB >> 23260002

Plasma DNA integrity indicates response to neoadjuvant chemotherapy in patients with locally confined breast cancer.

Julia Lehner1, Oliver J Stötzer, Debora M I Fersching, Dorothea Nagel, Stefan Holdenrieder.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23260002     DOI： 10.5414/cpp51059

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Ther        ISSN： 0946-1965            Impact factor:   1.366


× No keyword cloud information.
  4 in total

1.  Association of clinical outcomes in metastatic breast cancer patients with circulating tumour cell and circulating cell-free DNA.

Authors:  Zhong Ye; Chun Wang; Shaogui Wan; Zhaomei Mu; Zhenchao Zhang; Maysa M Abu-Khalaf; Frederick M Fellin; Daniel P Silver; Manish Neupane; Rebecca J Jaslow; Saveri Bhattacharya; Theodore N Tsangaris; Inna Chervoneva; Adam Berger; Laura Austin; Juan P Palazzo; Ronald E Myers; Neha Pancholy; Darayus Toorkey; Kaelan Yao; Max Krall; Xiuling Li; Xiaobing Chen; Xiuhong Fu; Jinliang Xing; Lifang Hou; Qiang Wei; Bingshan Li; Massimo Cristofanilli; Hushan Yang
Journal:  Eur J Cancer       Date:  2018-12-04       Impact factor: 9.162

2.  Direct quantification of cell-free, circulating DNA from unpurified plasma.

Authors:  Sarah Breitbach; Suzan Tug; Susanne Helmig; Daniela Zahn; Thomas Kubiak; Matthias Michal; Tommaso Gori; Tobias Ehlert; Thomas Beiter; Perikles Simon
Journal:  PLoS One       Date:  2014-03-03       Impact factor: 3.240

3.  Prognostic value of the DNA integrity index in patients with malignant lung tumors.

Authors:  Dimple Y Chudasama; Zeynep Aladag; Mayla I Felicien; Marcia Hall; Julie Beeson; Nizar Asadi; Yori Gidron; Emmanouil Karteris; Vladimir B Anikin
Journal:  Oncotarget       Date:  2018-04-20

4.  Targeting Circulating SINEs and LINEs with DNase I Provides Metastases Inhibition in Experimental Tumor Models.

Authors:  Ludmila A Alekseeva; Aleksandra V Sen'kova; Marina A Zenkova; Nadezhda L Mironova
Journal:  Mol Ther Nucleic Acids       Date:  2020-02-08       Impact factor: 8.886
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.